Alzheimer’s disease is a very real condition that affects thousands of people across the world. For this reason, it is essential that doctors and scientists work together in order to find innovative ways in which to diagnose and treat this disease. Although there is no cure for this disease, doctors will be able to slow its progression and delay symptoms through various treatments. 

This is where Cognes comes in. Even though there are numerous ways in which doctors can test for Alzheimer’s, very few methods have proven to be as efficient and effective as Cognes. With that being said, MRI-PET scans are also used to diagnose this condition. 

If you have no idea what Cognes is, you have come to the right place. In this article, we will be discussing exactly what this diagnostic test involves and how it benefits the patient. More so, we will compare Cognes to another commonly used test – MRI/PET scans. 

Alzheimer’s Disease

Alzheimer’s disease is a very serious condition in which the brain stops functioning due to the loss of connection between neurons. This disease is the most common cause of dementia. Over time, the patient will lose brain function and begin to forget how to perform basic skills, such as speaking. 

This condition is irreversible and progressive. For this reason, it is essential that doctors diagnose patients early on to delay symptoms as much as possible. As of now, there is no cure for Alzheimer’s. However, with different treatments, patients will be able to lead a normal life for much longer. 

What Is Cognes?

Before we can talk about the benefits of Cognes, it is essential that you understand precisely what Cognes is and how it works. In short, this diagnostic test is a non-invasive procedure that can be used to detect early signs of Alzheimer’s disease. More so, this test can be carried out anywhere, at any time, and by anyone.

Unfortunately, more than half of Alzheimer’s patients across the world are completely unaware of the fact that they have the condition. This is partially due to the fact that many scans and tests do not display the early warning signs of the disease. 

However, thanks to innovative technology and a better understanding of the condition itself, doctors and scientists have been able to work together in order to create a convenient and effective system that can help identify the early signs of Alzheimer’s progression. 

In other words, Cognes has been able to diagnose thousands of Alzheimer’s patients around the world, leading to earlier treatment and delayed symptoms. 

The Competitive Benefits Of Cognes

There are a number of benefits that come with Cognes tests. For starters, the diagnostic test can be completed in under 5 minutes. More so, patients will receive their results within just 5 hours of the test being conducted. 

When compared to other Alzheimer’s tests, Cognes is exceptionally cost-efficient. In fact, it will cost a patient around $5000 for the entire process. Even though this may seem pricey, it is low relative to the other diagnostic procedures. 

Lastly, Cognes tests are highly scalable. These tests can be used at home and are successful in biomarker identification. 

MRI And PET-Scans

We now understand what Cognes scans are and how they are used. So, how do MRI and PET scans compare to this diagnostic test?

In short, MRI scans use radio waves and magnets to produce still images of the body’s internal structures. On the other hand, a PET scan uses radioactive tracers to show how an organ is functioning in real-time. It is important to note that PET scans detect cellular changes much sooner than MRI scans. 

Some doctors now rely on a hybrid test called the PET/MRI scan. This innovative technology provides high-contrast images that can be used to diagnose and test the internal structure of the body. 

What Is Biomarker Identification?

Biomarkers are also commonly referred to as biological markers. In short, they can be tracked by a biomarker identifier in order to diagnose a biological situation or case. On top of this, these identifiers can detect the presence of biological processes and activities. 

One commonly used type of biomarker is a protein. Proteins are naturally occurring molecules that can be used to identify certain illnesses, diseases, and conditions. In other words, it can be defined as a biological marker. 

Biomarker identification is frequently used to diagnose severe conditions and illnesses. This method is also used for patients who suffer from Alzheimer’s disease.

MRI And PET-Scans For Biomarker Identification

MRI and PET scans are often used to diagnose Alzheimer’s disease. While there are a number of benefits that come with using this type of diagnostic test, it is still not as commonly used as Cognes for various reasons. 

MRI/PET-Scans are not available for home use. In other words, they are nowhere near as convenient as Cognes tests. On top of this, they are not as scalable. 

MRI/PET-Scans can be used to detect brain abnormalities associated with Alzheimer’s disease. To be more specific, these abnormalities are associated with mild cognitive impairment (MCI). Doctors use this information to predict exactly which patients will develop Alzheimer’s in the future. In this way, they will be able to diagnose patients early on and provide them with the necessary treatments to delay serious symptoms of the disease. 

Conclusion

Alzheimer’s disease is a very serious condition in which patients progressively lose brain function. There is no cure for Alzheimer’s; however, through various treatments, doctors will be able to delay symptoms and slow the disease’s progression. 

There are several ways in which this condition can be diagnosed. This includes CTs and MRI/PET scans. Through MRI and PET scans, doctors are able to identify biomarkers within the body.